A new catheter to simplify portal vein cannulation for adjuvant cytotoxic liver perfusion following resection of rectal cancer.
Evidence from randomised clinical trials suggests that adjuvant cytotoxic liver perfusion with 5-fluorouracil following resection of colorectal carcinoma may improve survival in some patients. Various methods of cannulating the portal vein or a tributary at the time of surgery have been described. We describe a simple method of accessing the portal venous circulation via a tributary in the small bowel mesentery, employing a new type of polyurethane catheter. The technical details are discussed with reference to previous literature.
Ashley
S
S
University Surgical Unit, Royal South Hampshire Hospital, Southampton, UK.
Sutton
G
G
Royle
G
G
Taylor
I
I
D002406:Catheterization, Peripheral / Q000295:instrumentation*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D011169:Portal Vein; D011184:Postoperative Period; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000601:surgery*
D005472:Fluorouracil